The pharmacokinetics of low-dose thalidomide in Japanese patients with refractory multiple myeloma

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 11, 2006, Pages 2331-2334

  Kamikawa, Rintaro ^a   Ikawa, Kazuro ^b   Morikawa, Norifumi ^b   Asaoku, Hideki ^a   Iwato, Koji ^a   Sasaki, Ayako ^c  

^a ATOMIC BOMB SURVIVORS HOSPITAL   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c Motonaga Hospital   (Japan)

Author keywords

Multiple myeloma; Pharmacokinetics; Thalidomide

Indexed keywords

THALIDOMIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; BLOOD TOXICITY; CAUCASIAN; CLINICAL ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG WITHDRAWAL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; JAPAN; LEG EDEMA; MALE; MEAL; MULTIPLE MYELOMA;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; CAPSULES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MULTIPLE MYELOMA; THALIDOMIDE; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

EID: 33750608892     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.2331     Document Type: Article

References (17)

1. Eriksson T., Bjorkman S., Hoglund P., Eur. J. Clin. Pharmacol., 57, 365-376 (2001).
2. Juliusson G., Celsing F., Turesson I., Lenhoff S., Adriansson M., Malm C., Br. J. Haematol., 109, 89-96 (2000).
3. Tosi P., Zamagni E., Cellini C., Ronconi S., Patriarca F., Ballerini F., Musto P., Di Raimondo F., Ledda A., Lauria F., Masini L., Gobbi M., Vacca A., Ria R., Cangini D., Tura S., Baccarani M., Cavo M., Haematologica, 87, 408-414 (2002).
4. Kakimoto T., Hattori Y., Okamoto S., Sato N., Kamata T., Yamaguchi M., Morita K., Yamada T., Takayama N., Uchida H., Shimada N., Tanigawara Y., Ikeda Y., Jpn. J. Cancer Res., 93, 1029-1036 (2002).
5. Murakami H., Handa H., Imai K., Kanakura Y., Kosaka M., Sawamura M., Shimazaki C., Suzuki K., Ishii A., Takagi T., Taniwaki M., Togawa A., Hata H., Wakayama T., Takatsuki K., Rinsho Ketsueki, 45, 468-472 (2004).
6. Barlogie B., Desikan R., Eddlemon P., Spencer T., Zeldis J., Munshi N., Badros A., Zangari M., Anaissie E., Epstein J., Shaughnessy J., Ayers D., Spoon D., Tricot G., Blood, 98, 492-494 (2001).
7. Raza A., Meyer P., Dutt D., Zorat F., Lisak L., Nascimben F., du Randt M., Kaspar C., Goldberg C., Loew J., Dar S., Gezer S., Venugopal P., Zeldis J., Blood, 98, 958-965 (2001).
8. Zhou S., Li Y., Kestell P., Paxton J. W., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 785, 165-173 (2003).
9. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
10. Teo S. K., Colburn W. A., Thomas S. D., J. Clin. Pharmacol., 39, 1162-1168 (1999).
11. Piscitelli S. C., Figg W. D., Hahn B., Kelly G., Thomas S., Walker R. E., Antimicrob. Agents Chemother., 41, 2797-2799 (1997).
12. Teo S. K., Colburn W. A., Tracewell W. G., Kook K. A., Stirling D. I., Jaworsky M. S., Scheffler M. A., Thomas S. D., Laskin O. L., Clin. Pharmacokinet., 43, 311-327 (2004).
13. Chung F., Lu J., Palmer B. D., Kestell P., Browett P., Baguley B. C., Tingle M., Ching L. M., Clin. Cancer Res., 10, 5949-5956 (2004).
14. Tredger J. M., Brown N. W., Adams J., Gonde C. E., Dhawan A., Rela M., Heaton N., Liver Transpl., 10, 492-502 (2004).
15. Pawinski T., Durlik M., Szlaska I., Urbanowicz A., Ostrowska J., Gralak B., Majchrzak J., Transplant. Proc., 38, 86-89 (2006).
16. Teo S. K., Scheffler M. R., Kook K. A., Tracewell W. G., Colburn W. A., Stirling D. I., Thomas S. D., J. Clin. Pharmacol., 41, 662-667 (2001).
17. Hattori Y., Iguchi T., Congenit. Anom., 44, 125-136 (2004).